THQ(THQ)
THQ
10/14/26
Abrdn Healthcare Opportunities Fund (THQ)
Wednesday
8:13 AM
ThesisThe fund's strategic pivot towards high-demand healthcare sectors and recent acquisitions are generating positive sentiment among investors…
Revenue Outlook
What’s Driving the Stock
- 01Recent acquisition of a promising biotech firm with a pipeline of three drugs in late-stage trials could enhance future returns significantly.
- 02Increased allocation to telehealth companies, which have seen a 150% increase in demand post-pandemic, positioning the fund for growth.
- 03Potential regulatory approval for a key drug in the portfolio could lead to significant appreciation in asset values.
- 04Market sentiment is shifting towards healthcare as a defensive play amid economic uncertainty, increasing fund attractiveness.
- 05Telehealth expansion post-pandemic
- 06Increased investment in biotech innovation
- 07Changes in healthcare policy impacting investment opportunities
- 08Performance of underlying healthcare assets in the portfolio
FY2025 Snapshot
- Revenue
- $-101M
- Rev. Growth
- -153%
- Gross Margin
- 113%
- Op. Margin
- 114%
- Net Margin
- 114%
- Net Income
- $-115M
- NI Growth
- -161%
- EPS
- $-2.78
- 1Y Return
- +11.2%
THQ Chart
My Notes
- "Investors are increasingly viewing healthcare as a resilient sector amidst economic fluctuations."
- Moat: The fund's specialized focus on healthcare provides a durable competitive advantage…
- growth - Investors seeking exposure to high-growth healthcare opportunities will find this fund appealing.
- Higher interest rates can increase borrowing costs for healthcare companies, potentially impacting their growth and profitability…
- Watch on earnings: Healthcare sector performance indices, AUM growth rate, Net inflows/outflows.
One Sentence Summary:
Abrdn Healthcare Opportunities Fund: the setup is constructive — recent acquisition of a promising biotech firm with a pipeline of three drugs in late-stage trials could enhance future returns.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
Explore More
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance